Dose adjustments and discontinuation in TNF inhibitors treated patients: when and how. A systematic review of literature

摘要

Objectives. To review the available evidence concerning the possibility of discontinuing and/ or tapering the dosage of TNF inhibitors (TNFi) in RA patients experiencing clinical remission or low disease activity.